Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker’s Bureau - Aria; Boehringer Ingelheim; Edwards Lifesciences; Eli Lilly; Merck; VaDovations; Janssen Pharmaceuticals; Novo Nordisk; NGMBio; ShouTi
• Grant Support/Research Contract - Novo Nordisk; AstraZenca; Corvia; Medtronic; NIH/NHLBI; Tenax; DoD; Axon Therapies; Rivus